Celtaxsys - Biology in Reverse

Michael W. Masters, Masters Capital Management

Mr. Masters is the Founder and Portfolio Manager of Masters Capital Management, LLC. Masters Capital is a global investment management firm that trades and invests in public and private domestic and international bonds and equities. In 1994, Mr. Masters organized Masters Capital and became its general partner and President. Masters Capital currently manages a family of alternative assets, and is based in St. Croix, USVI.

Matthew Dontzin, Esq., Dontzin Law Firm

Mr. Dontzin is the Managing Partner of The Dontzin Law Firm, LLP. He represents individuals and corporate clients in the United States and abroad in a wide range of matters, including international litigation and arbitration, complex commercial litigation, securities and derivatives litigation, criminal defense, and complex business transactions, with a particular emphasis on private equity transactions. Mr. Dontzin has devised and coordinated litigation strategy for civil and criminal proceedings involving $50 billion under the laws of seven jurisdictions, and has supervised over 135 lawyers from 30 firms of international repute. He has tried cases in the U.S. District Courts for the Southern and Eastern Districts of New York and the New York Supreme Court, and has argued appeals in the U.S. Courts of Appeals for the Second and Third Circuits and the New York Supreme Court, Appellate Division.

Jan M. Lodal, Lodal & Company

Mr. Lodal is the Chairman of Lodal & Company. He served as President of the Atlantic Council of the United States from October 2005 until the end of 2006. Previously, he served as Principal Deputy Under Secretary of Defense for Policy and as a senior staff member of the National Security Council. He was Founder, Chairman, and CEO of Intelus Inc. and Co-Founder of American Management Systems, Inc. During the Nixon and Ford administrations, Mr. Lodal served on the White House staff as Deputy for Program Analysis to Henry A. Kissinger, and during the Johnson administration as Director of the NATO and General Purpose Force Analysis Division in the Office of the Secretary of Defense. Mr. Lodal is a member of the Board of Overseers of the Curtis Institute of Music, a Trustee of the American Boychoir, and a member of the Council on Foreign Relations and the International Institute of Strategic Studies. He was previously Executive Director of the Aspen Strategy Group and President of Group Health Association. He is the author of numerous articles on public policy, arms control, and defense policy, and of The Price of Dominance: the New Weapons of Mass Destruction and their Challenge to American Leadership.

Michael Hanley, Ph.D. , Amylin Pharmaceuticals

Dr. Hanley is the Vice President of Discovery Research at Amylin Pharmaceuticals. He was a Senior Consultant for Cell Therapeutics, Zymogenetics, Elan Pharmaceuticals, and Chiron Corporation. Prior to that he held Professor positions at the Imperial College, London, the Medical Research Council Laboratories, Cambridge, and the University of California at Davis. Michael has served on advisory or review panels for the NIH, the Medical Research Council and Wellcome Trust of Great Britain, and for the governments of Australia, Singapore, New Zealand, Hong Kong, Denmark and Japan. He has set-up and directed research programs in privately-held start-ups, such as Chemocentryx, PsychoGenics, and most recently Harvard-based Resolvyx Pharmaceuticals.

William P. ('Bill') Reddick, M. H. A.

Mr. Reddick held various management positions with Arthur Andersen and The Hospital Authority of Fulton County, Georgia. From 1994-2005, Mr. Reddick was Co-founder, Healthcare Analyst, and the Director of Research for Masters Capital Management, a hedge fund. During that time Mr. Reddick worked extensively with public and private biotechnology and medical device companies. Mr. Reddick is a graduate of Eastern Kentucky University (B.B.A.) and the University of Houston (M.H.A.). Since 2005 Mr. Reddick has been the President of Celtaxsys and is a member of the Board of Directors.